TMEM170B and breast carcinoma: For instance, Li et al. reported that miRNA-27a, by targeting transmembrane protein 170B (TMEM170B) and inhibiting the Wnt/β-catenin pathway could suppress breast cancer proliferation, migration, and tumorigenesis [71].